Table 5. Univariate Cox models for DLBCL, NOS patients treated with R-CHOP.

		OS			PFS
Characteristic	n#	HR	95% CI	P	HR	95% CI	P
MYC protein low vs. High	118	4.39	2.02–9.54	<0.001	2.87	1.66–4.99	<0.001
BCL2 protein low vs. High	118	1.86	0.92–3.73	0.083	1.47	0.86–2.51	0.157
BCL6 protein low vs. High	118	0.33	0.14–0.80	0.014	0.71	0.40–1.26	0.238
High Ki67 protein low vs. High	118	2.09	1.04–4.23	0.040	1.72	1.01–2.95	0.047
MYC/BCL2 DHS 0 vs. 1 vs. 2	118	2.76	1.66–4.60	<0.001	2.03	1.39–2.96	<0.001
MYC/BCL6 DHS 0 vs. 1 vs. 2	118	4.23	2.29–7.79	<0.001	2.25	1.47–3.45	<0.001
BCL2/BCL6 DHS 0 vs. 1 vs. 2	118	2.11	1.26–3.52	0.005	1.37	0.95–1.97	0.089
THS 0 vs. 1 vs. 2 vs. 3	118	2.54	1.70–3.81	<0.001	1.72	1.28–2.31	<0.001
GCB vs. non-GCB	118	1.67	0.69–4.06	0.259	1.97	0.96–4.03	0.064
IPI score of 0–2 vs. 3–5	118	1.76	0.79–3.92	0.167	1.74	0.91–3.30	0.093
MYC break negative vs. positive	57	0.52	0.07–3.98	0.529	1.19	0.42–3.41	0.740
IGH/BCL2 fusion negative vs. positive	55	1.74	0.48–6.36	0.402	0.90	0.32–2.59	0.851
BCL6 break negative vs. positive	57	1.04	0.29–3.81	0.948	1.27	0.59–2.73	0.550

Bold font indicates significance.

^#Sample sizes differ due to complete data set per cox model.